MAGELLAN LONGEVITY
HomeResearchStudy library › Short-term effects of fine particulate matter on daily health events…
Study summary · Environment, air, water & exposures

What are the short-term effects of fine particulate matter (PM2.5) exposure on morbidity and mortality in Latin America?

In one paragraph

Short-term effects of fine particulate matter, a systematic review and meta-analysis (Int J Public Health 2017, PMID 28255648) — a 10 µg/m3 increment in daily PM2.5 concentrations was significantly associated with an increased risk for respiratory mortality in all ages (pooled RR = 1.02, 95% CI, 1.02-1.02) and cardiovascular mortality (pooled RR = 1.01, 95% CI, 1.01-1.02).

Source: Int J Public Health 2017, PMID 28255648 ↗ · Research map · How Magellan grades evidence · evidence confidence: high

Int J Public Health · 2017 · PMID 28255648 · DOI 10.1007/s00038-017-0960-y

Plain-English summary written and published by Magellan Longevity · medical review by Gabriel Radu, DO (physiatrist, NPI 1376861765). We summarize what the paper reported — we did not run this study.

The takeaway

Short-term exposure to fine particulate matter in Latin America is linked to higher risks of respiratory and cardiovascular deaths.

The question

What are the short-term effects of fine particulate matter (PM2.5) exposure on morbidity and mortality in Latin America?

What they tested

The study hypothesized that short-term exposure to PM2.5 would be associated with increased morbidity and mortality in Latin America.

How they did it

A systematic review and meta-analysis were conducted, searching six online databases and hand-searching for studies investigating short-term associations between PM2.5 and daily health events in Latin America. Two reviewers independently assessed study internal validity, and random-effect models were used for the meta-analysis.

What they found

Out of 1628 retrieved studies, nine were selected for qualitative analysis and seven for quantitative analysis. A 10 µg/m3 increment in daily PM2.5 concentrations was significantly associated with an increased risk for respiratory mortality in all ages (pooled RR = 1.02, 95% CI, 1.02-1.02) and cardiovascular mortality (pooled RR = 1.01, 95% CI, 1.01-1.02).

Increased Risk for Mortality per 10 µg/m3 PM2.5 Increment
Values shown: Pooled Relative Risk (RR)
Respiratory Mortality1.02
Cardiovascular Mortality1.01

Each 10 µg/m3 increase in daily PM2.5 concentrations was associated with a 2% increased risk for respiratory mortality and a 1% increased risk for cardiovascular mortality.

What it means

Short-term exposure to PM2.5 in Latin America is significantly associated with an increased risk for respiratory and cardiovascular mortality.

Limitations

The evidence is concentrated in a few cities, and some studies presented a high risk of bias.

“short-term exposure to PM2.5 is significantly associated with increased respiratory and cardiovascular mortality”— from the published abstract, Int J Public Health 2017

The paper at a glance

TitleShort-term effects of fine particulate matter on daily health events in Latin America: a meta-analysis
JournalInt J Public Health
Year2017
PMID28255648 ↗
DOI10.1007/s00038-017-0960-y ↗
TopicEnvironment, air, water & exposures

Read the source: PubMed record (authors, abstract, full citation) ↗ · Publisher via doi.org ↗

Where Magellan uses this paper

This citation sits behind the evidence grade on the pages below. Grades are set from the research and are independent of affiliate commissions.

Personal PM2.5 Air Monitor

Long-term exposure to PM2.5 is one of the most consistently documented environmental risk factors for human disease and premature death. Large cohorts and meta-analyses link higher PM2.5 to increased all-cause and cardiovascular mortality — about 16% and 28% higher per 10 µg/m³ in the Harvard Six Cities extended…

Personal PM2.5 Air Monitor

PM2.5 refers to fine particulate matter, airborne particles with an aerodynamic diameter of 2.5…

Check price on Amazon ↗

Research describes the compound or intervention studied. It is not a claim about any specific product.

Molecules & mechanisms in this paper

Each of these is named in the paper’s own words above. Open the monograph for the full mechanism and its other citations.

Cite this page

These citations point at this summary. To cite the original paper with its full author list, use the PubMed record or doi.org.

APA
Magellan Longevity. (2026). What are the short-term effects of fine particulate matter (PM2.5) exposure on morbidity and mortality in Latin America? [Plain-English summary of Int J Public Health 2017, PMID 28255648, DOI 10.1007/s00038-017-0960-y]. Magellan Longevity. https://magellanlongevity.com/study/d28255648.html
BibTeX
@misc{magellan_d28255648, title = {What are the short-term effects of fine particulate matter (PM2.5) exposure on morbidity and mortality in Latin America?}, author = {{Magellan Longevity}}, year = {2026}, howpublished = {\url{https://magellanlongevity.com/study/d28255648.html}}, note = {Plain-English summary of PubMed PMID 28255648; DOI 10.1007/s00038-017-0960-y; Int J Public Health 2017. Reviewed by Gabriel Radu, DO}, urldate = {2026-08-11} }
Permalink
https://magellanlongevity.com/study/d28255648.html

Related studies in the Magellan library

All 19 Magellan summaries on environment, air, water & exposures →

How this summary was made. Every section above restates what the published abstract of PMID 28255648 reports — the question, the design, the numbers, the authors’ own conclusion and their stated limitations. We do not add claims the paper did not make, and we keep negative and no-effect findings in. Magellan’s evidence grades are set from research like this and never from affiliate commissions.

Prefer the interactive version? Open this summary in the Magellan app → · Browse all 314 study summaries →

Educational information, not medical advice. This is a plain-English summary of published research; it is not a treatment recommendation and nothing here is intended to diagnose, treat, cure, or prevent any disease. Individual studies can be wrong, and a single paper rarely settles a question. Talk to your physician before acting on any research, especially if you are pregnant, nursing, or taking medication.